Discovering DALRD3: A Potential Drug Target and Biomarker (G55152)

Target Name: DALRD3

NCBI ID: G55152

DALRD3

Discovering DALRD3: A Potential Drug Target and Biomarker

DALRD3 (DALD3_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. The protein is a member of the DAL family, which includes several related proteins that are involved in various cellular processes, including cell signaling, DNA replication, and metabolism.

DALRD3 is expressed in a variety of human tissues, including muscle, pancreas, and brain. It is also expressed in the placenta, which is the site of pregnancy and fetal development. The protein is involved in several cellular processes, including cell signaling, cell division, and metabolism.

One of the key functions of DALRD3 is its role in cell signaling. The protein is involved in the regulation of several signaling pathways, including the TGF-β pathway and the Wnt pathway. TGF-β is a signaling pathway that is involved in cell growth, differentiation, and repair, while the Wnt pathway is involved in cell development and stem cell maintenance.

DALRD3 is also involved in cell division. The protein is involved in the regulation of cell division, including the G1/S transition, which is the stage of cell growth and preparation for cell division. This regulation is important for the maintenance of tissue homeostasis and for the development and maintenance of tissues.

In addition to its role in cell signaling and cell division, DALRD3 is also involved in metabolism. The protein is involved in the regulation of glucose metabolism, including the uptake and storage of glucose in the cell. This regulation is important for maintaining energy homeostasis and for the proper functioning of the body.

DALRD3 is also a potential drug target. Its involvement in multiple cellular processes makes it an attractive target for small molecules and other therapeutic compounds. In addition, its expression in several human tissues makes it a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease.

The discovery and characterization of DALRD3 as a potential drug target or biomarker has important implications for the development of new treatments for a variety of diseases. While further research is needed to fully understand its functions and potential as a drug target, its expression and regulation in multiple human tissues make it an promising candidate for further study.

Protein Name: DALR Anticodon Binding Domain Containing 3

Functions: Involved in tRNA methylation. Facilitates the recognition and targeting of tRNA(Arg)(CCU) and tRNA(Arg)(UCU) substrates for N(3)-methylcytidine modification by METTL2A and METTL2B

The "DALRD3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DALRD3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets